By Professor Bruce Neal

Journal articles

Tye SC; Oshima M; Arnott C; Neuen BL; Fletcher RA; Neal B; Heerspink HJL, 2023, 'The importance of targeting multiple risk markers in patients with type 2 diabetes: A post-hoc study from the CANVAS programme', Diabetes, Obesity and Metabolism, 25, pp. 1638 - 1645, http://dx.doi.org/10.1111/dom.15018

Karlsson K; Radholm K; Dunford E; Wu J; Neal B; Sundstrom J, 2023, 'Sodium content in Swedish processed food items compared to other countries', European Journal of Preventive Cardiology, 30, http://dx.doi.org/10.1093/eurjpc/zwad125.028

Yin X; Paige E; Tian M; Li Q; Huang L; Yu J; Rodgers A; Elliott P; Wu Y; Neal B, 2023, 'The Proportion of Dietary Salt Replaced with Potassium-Enriched Salt in the SSaSS: Implications for Scale-Up', Hypertension, 80, pp. 956 - 965, http://dx.doi.org/10.1161/HYPERTENSIONAHA.122.20115

Sundström J; Lind L; Nowrouzi S; Hagström E; Held C; Lytsy P; Neal B; Marttala K; Östlund O, 2023, 'Heterogeneity in Blood Pressure Response to 4 Antihypertensive Drugs: A Randomized Clinical Trial', JAMA, 329, pp. 1160 - 1169, http://dx.doi.org/10.1001/jama.2023.3322

Yuan Y; Jin A; Neal B; Feng X; Qiao Q; Wang H; Zhang R; Li J; Duan P; Cao L; Zhang H; Hu S; Li H; Gao P; Xie G; Yuan J; Cheng L; Wang S; Zhang H; Niu W; Fang H; Zhao M; Gao R; Chen J; Elliott P; Labarthe D; Wu Y, 2023, 'Salt substitution and salt-supply restriction for lowering blood pressure in elderly care facilities: a cluster-randomized trial', Nature Medicine, 29, pp. 973 - 981, http://dx.doi.org/10.1038/s41591-023-02286-8

Bowman L; Weidinger F; Albert MA; Fry ETA; Pinto FJ; Achenbach S; Casadei B; Collins R; Devereaux PJ; Douglas PS; Frobert O; Goto S; Grines C; Harrington RA; Haynes R; Hochman JS; James S; Kirchhof P; Komajda M; Lam CSP; Landray M; Maggioni A; Mcmurray J; Medhurst N; Neal B; Rydén L; Thiele H; Van Gelder I; Wallentin L; Yusuf S; Zannad F, 2023, 'Randomized Trials Fit for the 21st Century: A Joint Opinion From the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation', Circulation, 147, pp. 925 - 929, http://dx.doi.org/10.1161/CIRCULATIONAHA.122.063378

Trieu K; Coyle DH; Rosewarne E; Shahid M; Yamamoto R; Nishida C; Neal B; He FJ; Marklund M; Wu JHY, 2023, 'Estimated Dietary and Health Impact of the World Health Organization's Global Sodium Benchmarks on Packaged Foods in Australia: A Modeling Study', Hypertension, 80, pp. 541 - 549, http://dx.doi.org/10.1161/HYPERTENSIONAHA.122.20105

Marklund M; Cherukupalli R; Pathak P; Neupane D; Krishna A; Wu JHY; Neal B; Kaur P; Moran AE; Appel LJ; Matsushita K, 2023, 'Hypertension treatment capacity in India by increased workforce, greater task-sharing, and extended prescription period: a modelling study', The Lancet Regional Health - Southeast Asia, 10, pp. 100124, http://dx.doi.org/10.1016/j.lansea.2022.100124

Grimes CA; Bolton KA; Lim K; Khokhar D; Santos JA; Trieu K; Margerison C; Reimers J; Armstrong S; Bolam B; Rosewarne E; Dunford EK; Jan S; Woodward M; Neal B; Nowson C; Webster J; Santos JA, 2023, 'Evaluation of a Salt-Reduction Consumer Awareness Campaign Targeted at Parents Residing in the State of Victoria, Australia', Nutrients, 15, pp. 991, http://dx.doi.org/10.3390/nu15040991

Atkins ER; Chye A; Lung T; Nolde JM; Billot L; Burke M; Chalmers J; Figtree GA; Hay P; Hillis GS; Jansen S; Marschner S; Neal B; Nelson MR; Reid CM; Usherwood T; Schlaich M; Chow CK; Rodgers A, 2023, 'Cost-effectiveness of ultra-low-dose quadruple combination therapy for high blood pressure', Heart, 109, pp. 1698 - 1705, http://dx.doi.org/10.1136/heartjnl-2022-322300

Eyles H; Grey J; Jiang Y; Umali E; McLean R; Morenga LT; Neal B; Rodgers A; Doughty RN; Mhurchu CN, 2023, 'Effectiveness of a Sodium-Reduction Smartphone App and Reduced-Sodium Salt to Lower Sodium Intake in Adults With Hypertension: Findings From the Salt Alternatives Randomized Controlled Trial', JMIR mHealth and uHealth, 11, pp. e43675, http://dx.doi.org/10.2196/43675

Bolton KA; Santos JA; Rosewarne E; Trieu K; Reimers J; Nowson C; Neal B; Webster J; Woodward M; Dunford E; Armstrong S; Bolam B; Grimes C; Santos JA, 2023, 'Outcomes of a state-wide salt reduction initiative in adults living in Victoria, Australia', European Journal of Nutrition, 62, pp. 3055 - 3067, http://dx.doi.org/10.1007/s00394-023-03210-z

Ojo AE; Jones A; Okoro CE; Alfa VO; Okoli R; Shedul GL; Orji IA; Osagie S; Chopra A; Van Horn LV; Hirschhorn LR; Trieu K; Taylor F; Howes K; Ilias M; Williams MJ; Tutse-Tonwe V; Neal B; Huffman MD; Ojji DB, 2023, 'Sodium Content and Labelling of Packaged Foods and Beverages in Nigeria: A Cross-Sectional Study', Nutrients, 15, pp. 27, http://dx.doi.org/10.3390/nu15010027

Karlsson K; Rådholm K; Dunford E; Wu JHY; Neal B; Sundström J, 2023, 'Sodium content in processed food items in Sweden compared to other countries: a cross-sectional multinational study', Frontiers in Public Health, 11, pp. 1182132, http://dx.doi.org/10.3389/fpubh.2023.1182132

Sanuade OA; Alfa V; Yin X; Liu H; Ojo AE; Shedul GL; Ojji DB; Huffman MD; Orji IA; Okoli RCB; Akor B; Ripiye NR; Eze H; Okoro CE; Van Horn L; Tripathi P; Ojo TM; Trieu K; Neal B; Hirschhorn LR, 2023, 'Stakeholder perspectives on Nigeria's national sodium reduction program: Lessons for implementation and scale-up', PLoS ONE, 18, pp. e0280226, http://dx.doi.org/10.1371/journal.pone.0280226

Jain SS; Yu J; Arnott C; Neal B; Perkovic V; Neuen BL; Jardine M; Mahaffey KW, 2023, 'Treatment effect of canagliflozin for patients on therapy for heart failure: Pooled analysis of the CANVAS program and CREDENCE trial', International Journal of Cardiology, 395, http://dx.doi.org/10.1016/j.ijcard.2023.131444

Koshino A; Neuen BL; Oshima M; Toyama T; Hara A; Arnott CG; Neal B; Jardine M; Badve S; Mahaffey KW; Pollock CA; Hansen MK; Wada T; Heerspink HJ, 2023, 'Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients with Type 2 Diabetes and CKD: A Post Hoc Analysis of the CREDENCE Trial', Journal of the American Society of Nephrology, 34, pp. 140 - 140, http://dx.doi.org/10.1681/asn.20233411s1140b

Genovese F; Rasmussen DGK; Neal B; Karsdal MA; Hansen MK, 2023, 'Canagliflozin Treatment Impact on Collagen Type III Turnover Is Associated with a Reduced Mortality Risk in CANVAS', Journal of the American Society of Nephrology, 34, pp. 136 - 136, http://dx.doi.org/10.1681/asn.20233411s1136a

Barrett EM; Afrin H; Rayner M; Pettigrew S; Gaines A; Maganja D; Jones A; Mozaffarian D; Beck EJ; Neal B; Taylor F; Munn E; Wu JH, 2023, 'Criterion validation of nutrient profiling systems: a systematic review and meta-analysis', American Journal of Clinical Nutrition, 119, http://dx.doi.org/10.1016/j.ajcnut.2023.10.013

Koshino A; Neuen BL; Arnott CG; Neal B; Jardine M; Badve S; Mahaffey KW; Pollock CA; Hansen MK; Wada T; Heerspink HJ, 2023, 'Iron Biomarkers and Effects of Canagliflozin in Patients with Type 2 Diabetes and CKD: A Post Hoc Analysis of the CREDENCE Trial', Journal of the American Society of Nephrology, 34, pp. 140 - 140, http://dx.doi.org/10.1681/asn.20233411s1140c

Shahid M; Gaines A; Coyle D; Alessandrini R; Finnigan T; Frost G; Marklund M; Neal B, 2023, 'P29-040-23 The Effect of Mycoprotein Intake on Biomarkers of Human Health: A Systematic Review and Meta-Analysis', Current Developments in Nutrition, 7, pp. 101428 - 101428, http://dx.doi.org/10.1016/j.cdnut.2023.101428

Carcel C; Neal B; Rogers K; Oparil S; Narkiewicz K; Wang J; Schiffrin EL; Azizi M; Poulter N; Chalmers J, 2023, 'S-16-1: RESISTANT HYPERTENISION: CLINICAL CHARACTERISTICS AND BLOOD PRESSURE CONTROL', Journal of Hypertension, 41, pp. e42, http://dx.doi.org/10.1097/01.hjh.0000913112.64878.4e

Jain SS; Yu J; Arnott C; Neal BC; Perkovic V; Neuen B; Jardine M; Mahaffey KW, 2023, 'TREATMENT EFFECT OF CANAGLIFLOZIN FOR PATIENTS ON THERAPY FOR HEART FAILURE: POOLED ANALYSIS OF THE CANVAS PROGRAM AND CREDENCE TRIAL', Journal of the American College of Cardiology, 81, pp. 283, http://dx.doi.org/10.1016/s0735-1097(23)00727-1

Rasmussen DGK; Hansen MK; Blair J; Jatkoe TA; Neal B; Karsdal MA; Genovese F, 2022, 'Endotrophin is a risk marker of complications in CANagliflozin cardioVascular Assessment Study (CANVAS): a randomized controlled trial', Cardiovascular Diabetology, 21, pp. 261, http://dx.doi.org/10.1186/s12933-022-01666-7

Tye SC; Jongs N; Coca SG; Sundström J; Arnott C; Neal B; Perkovic V; Mahaffey KW; Vart P; Heerspink HJL, 2022, 'Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney and heart failure outcomes guided by HbA1c, albuminuria, and predicted risk of kidney failure', Cardiovascular Diabetology, 21, pp. 194, http://dx.doi.org/10.1186/s12933-022-01619-0

Coyle DH; Huang L; Shahid M; Gaines A; Di Tanna GL; Louie JCY; Pan X; Marklund M; Neal B; Wu JHY, 2022, 'Socio-economic difference in purchases of ultra-processed foods in Australia: an analysis of a nationally representative household grocery purchasing panel', International Journal of Behavioral Nutrition and Physical Activity, 19, pp. 148, http://dx.doi.org/10.1186/s12966-022-01389-8

Crosby S; Rajadurai E; Jan S; Holden R; Neal B, 2022, 'The effects of government policies targeting ethics and governance processes on clinical trial activity and expenditure: a systematic review', Humanities and Social Sciences Communications, 9, pp. 266, http://dx.doi.org/10.1057/s41599-022-01269-3

Baigent C; Emberson JR; Haynes R; Herrington WG; Judge P; Landray MJ; Mayne KJ; Ng SYA; Preiss D; Roddick AJ; Staplin N; Zhu D; Anker SD; Bhatt DL; Brueckmann M; Butler J; Cherney DZI; Green JB; Hauske SJ; Heerspink HJL; Inzucchi SE; Jardine MJ; Liu CC; Mahaffey KW; McCausland FR; McGuire DK; McMurray JJV; Neal B; Neuen BL; Packer M; Perkovic V; Sabatine MS; Solomon SD; Vaduganathan M; Wanner C; Wheeler DC; Wiviott SD; Zannad F, 2022, 'Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials', The Lancet, 400, pp. 1788 - 1801, http://dx.doi.org/10.1016/S0140-6736(22)02074-8

Sarraju A; Bakris G; Cannon CP; Cherney D; Damaraju CV; Figtree GA; Gogate J; Greene T; Heerspink HJL; Januzzi JL; Neal B; Jardine MJ; Blais J; Kosiborod M; Levin A; Lingvay I; Weir MR; Perkovic V; Mahaffey KW, 2022, 'Cardiovascular Effects of Canagliflozin in Relation to Renal Function and Albuminuria', Journal of the American College of Cardiology, 80, pp. 1721 - 1731, http://dx.doi.org/10.1016/j.jacc.2022.08.772

Koshino A; Schechter M; Sen T; Vart P; Neuen BL; Neal B; Arnott C; Perkovic V; Ridker PM; Tuttle KR; Hansen MK; Heerspink HJL, 2022, 'Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS', Diabetes Care, 45, pp. 2644 - 2652, http://dx.doi.org/10.2337/dc22-0866

Wu JHY; Trieu K; Coyle D; Huang L; Wijesuriya N; Nallaiah K; Lung T; Di Tanna GL; Zheng M; Mozaffarian D; MacMillan F; Simmons D; Wu T; Twigg S; Gauld A; Constantino M; McGill M; Wong J; Neal B, 2022, 'Testing the Feasibility and Dietary Impact of a “Produce Prescription” Program for Adults with Undermanaged Type 2 Diabetes and Food Insecurity in Australia', Journal of Nutrition, 152, pp. 2409 - 2418, http://dx.doi.org/10.1093/jn/nxac152

Li C; Yu J; Hockham C; Perkovic V; Neuen BL; Badve SV; Houston L; Lee VYJ; Barraclough JY; Fletcher RA; Mahaffey KW; Heerspink HJL; Cannon CP; Neal B; Arnott C, 2022, 'Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta-analysis', Diabetes, Obesity and Metabolism, 24, pp. 1927 - 1938, http://dx.doi.org/10.1111/dom.14772

Yin X; Rodgers A; Perkovic A; Huang L; Li KC; Yu J; Wu Y; Wu JHY; Marklund M; Huffman MD; Miranda JJ; Di Tanna GL; Labarthe D; Elliott P; Tian M; Neal B, 2022, 'Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis', Heart, 108, pp. 1608 - 1615, http://dx.doi.org/10.1136/heartjnl-2022-321332

Marklund M; Tullu F; Thout SR; Yu J; Brady TM; Appel LJ; Neal B; Wu JHY; Gupta R, 2022, 'Estimated Benefits and Risks of Using a Reduced-Sodium, Potassium-Enriched Salt Substitute in India: A Modeling Study', Hypertension, 79, pp. 2188 - 2198, http://dx.doi.org/10.1161/HYPERTENSIONAHA.122.19072

Sen T; Koshino A; Neal B; Bijlsma MJ; Arnott C; Li J; Hansen MK; Ix JH; Heerspink HJL, 2022, 'Mechanisms of action of the sodium-glucose cotransporter-2 (SGLT2) inhibitor canagliflozin on tubular inflammation and damage: A post hoc mediation analysis of the CANVAS trial', Diabetes, Obesity and Metabolism, 24, pp. 1950 - 1956, http://dx.doi.org/10.1111/dom.14779

Maganja D; Trieu K; Reading M; Huang L; Hart AC; Taylor F; Stamatellis S; Arnott C; Feng X; Schutte AE; Di Tanna GL; Ni Mhurchu C; Cameron AJ; Huffman MD; Neal B; Wu JH, 2022, 'Protocol for a novel sodium and blood pressure reduction intervention targeting online grocery shoppers with hypertension – the SaltSwitch Online Grocery Shopping randomized trial', American Heart Journal, 252, pp. 70 - 83, http://dx.doi.org/10.1016/j.ahj.2022.06.007

Arnott C; Fletcher RA; Neal B, 2022, 'Sodium Glucose Cotransporter 2 Inhibitors, Amputation Risk, and Fracture Risk', Heart Failure Clinics, 18, pp. 645 - 654, http://dx.doi.org/10.1016/j.hfc.2022.03.008

Nadkarni GN; Takale D; Neal B; Mahaffey KW; Yavin Y; Hansen MK; Fleming F; Heerspink HJL; Coca SG, 2022, 'A Post Hoc Analysis of KidneyIntelX and Cardiorenal Outcomes in Diabetic Kidney Disease', Kidney360, 3, pp. 1599 - 1602, http://dx.doi.org/10.34067/KID.0002172022

Liu Y; Xiao S; Yin X; Gao P; Wu J; Xiong S; Hockham C; Hone T; Wu JHY; Pearson SA; Neal B; Tian M, 2022, 'Nation-Wide Routinely Collected Health Datasets in China: A Scoping Review', Public Health Reviews, 43, pp. 1605025, http://dx.doi.org/10.3389/phrs.2022.1605025

Nazarzadeh M; Bidel Z; Canoy D; Copland E; Bennett DA; Dehghan A; Davey Smith G; Holman RR; Woodward M; Gupta A; Adler AI; Wamil M; Sattar N; Cushman WC; McManus RJ; Teo K; Davis BR; Chalmers J; Pepine CJ; Rahimi K; Agodoa L; Algra A; Asselbergs FW; Beckett N; Berge E; Black H; Brouwers FPJ; Brown M; Bulpitt CJ; Byington B; Cutler J; Devereaux RB; Dwyer J; Estacio R; Fagard R; Fox K; Fukui T; Imai Y; Ishii M; Julius S; Kanno Y; Kjeldsen SE; Kostis J; Kuramoto K; Lanke J; Lewis E; Lewis J; Lievre M; Lindholm LH; Lueders S; MacMahon S; Mancia G; Matsuzaki M; Mehlum MH; Nissen S; Ogawa H; Ogihara T; Ohkubo T; Palmer C; Patel A; Pfeffer M; Poulter NR; Rakugi H; Reboldi G; Reid C; Remuzzi G; Ruggenenti P; Saruta T; Schrader J; Schrier R; Sever P; Sleight P; Staessen JA; Suzuki H; Thijs L; Ueshima K; Umemoto S; van Gilst WH; Verdecchia P; Wachtell K; Whelton P; Wing L; Yui Y; Yusuf S; Zanchetti A; Zhang ZY; Anderson C; Baigent C; Brenner BM; Collins R; de Zeeuw D; Lubsen J; Malacco E; Neal B; Perkovic V; Pitt B; Rodgers A; Rothwell P; Salimi-Khorshidi G; Sundström J, 2022, 'Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis', The Lancet Diabetes and Endocrinology, 10, pp. 645 - 654, http://dx.doi.org/10.1016/S2213-8587(22)00172-3

Crosby S; Rajadurai E; Jan S; Neal B; Holden R, 2022, 'The effects on clinical trial activity of direct funding and taxation policy interventions made by government: A systematic review', PLoS ONE, 17, pp. e0269021, http://dx.doi.org/10.1371/journal.pone.0269021

Bablani L; Ni Mhurchu C; Neal B; Skeels CL; Staub KE; Blakely T, 2022, 'Effect of voluntary Health Star Rating labels on healthier food purchasing in New Zealand: Longitudinal evidence using representative household purchase data', BMJ Nutrition, Prevention and Health, 5, pp. 227 - 234, http://dx.doi.org/10.1136/bmjnph-2022-000459

Li JW; Arnott C; Heerspink HJL; Mbiostat QL; Cannon CP; Wheeler DC; Charytan DM; Barraclough J; Figtree GA; Agarwal R; Bakris G; de Zeeuw D; Greene T; Levin A; Pollock C; Zhang H; Zinman B; Mahaffey KW; Perkovic V; Neal B; Jardine MJ, 2022, 'Effect of Canagliflozin on Total Cardiovascular Burden in Patients With Diabetes and Chronic Kidney Disease: A Post Hoc Analysis From the CREDENCE Trial', Journal of the American Heart Association, 11, pp. e025045, http://dx.doi.org/10.1161/JAHA.121.025045

Ferrannini E; Baldi S; Scozzaro T; Tsimihodimos V; Tesfaye F; Shaw W; Rosenthal N; Figtree GA; Neal B; Mahaffey KW; Perkovic V; Hansen MK, 2022, 'Fasting Substrate Concentrations Predict Cardiovascular Outcomes in the CANagliflozin cardioVascular Assessment Study (CANVAS)', Diabetes Care, 45, pp. 1893 - 1899, http://dx.doi.org/10.2337/dc21-2398

Juraschek SP; Wang D; McEvoy JW; Harrap S; Harris K; Mancia G; Marre M; Neal B; Patel A; Poulter NR; Williams B; Chalmers J; Woodward M; Selvin E, 2022, 'Effects of glucose and blood pressure reduction on subclinical cardiac damage: Results from ADVANCE', International Journal of Cardiology, 358, pp. 103 - 109, http://dx.doi.org/10.1016/j.ijcard.2022.04.044

Liao J; Kang A; Xia C; Young T; Di Tanna GL; Arnott C; Pollock C; Krishnan AV; Agarwal R; Bakris G; Charytan DM; de Zeeuw D; Heerspink HJL; Levin A; Neal B; Wheeler DC; Zhang H; Zinman B; Mahaffey KW; Perkovic V; Jardine MJ; Smyth B, 2022, 'The impact of canagliflozin on the risk of neuropathy events: A post-hoc exploratory analysis of the CREDENCE trial', Diabetes and Metabolism, 48, pp. 101331, http://dx.doi.org/10.1016/j.diabet.2022.101331

Barraclough JY; Yu J; Figtree GA; Perkovic V; Heerspink HJL; Neuen BL; Cannon CP; Mahaffey KW; Schutte AE; Neal B; Arnott C, 2022, 'Cardiovascular and renal outcomes with canagliflozin in patients with peripheral arterial disease: Data from the CANVAS Program and CREDENCE trial', Diabetes, Obesity and Metabolism, 24, pp. 1072 - 1083, http://dx.doi.org/10.1111/dom.14671

Li KC; Huang L; Tian M; Di Tanna GL; Yu J; Zhang X; Yin X; Liu Y; Hao Z; Zhou B; Feng X; Li Z; Zhang J; Sun J; Zhang Y; Zhao Y; Zhang R; Yu Y; Li N; Yan LL; Labarthe DR; Elliott P; Wu Y; Neal B; Lung T; Si L, 2022, 'Cost-Effectiveness of a Household Salt Substitution Intervention: Findings From 20 995 Participants of the Salt Substitute and Stroke Study', Circulation, 145, pp. 1534 - 1541, http://dx.doi.org/10.1161/CIRCULATIONAHA.122.059573

Neuen BL; Oshima M; Agarwal R; Arnott C; Cherney DZ; Edwards R; Langkilde AM; Mahaffey KW; McGuire DK; Neal B; Perkovic V; Pong A; Sabatine MS; Raz I; Toyama T; Wanner C; Wheeler DC; Wiviott SD; Zinman B; Heerspink HJL, 2022, 'Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People with Type 2 Diabetes: A Meta-Analysis of Individual Participant Data from Randomized, Controlled Trials', Circulation, 145, pp. 1460 - 1470, http://dx.doi.org/10.1161/CIRCULATIONAHA.121.057736

Schutte AE; Neal B, 2022, 'The sodium hidden in medication: a tough pill to swallow', European Heart Journal, 43, pp. 1756 - 1758, http://dx.doi.org/10.1093/eurheartj/ehab888

Back to profile page